SCHEMBL3822181

SCHEMBL3822181

CCOC(=O)c1oc(CN)nc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.41
KDM4E B2RXH2 7/20 0.40
AHR P35869 1/20 0.40
MAPK1 P28482 1/20 0.39
CYP1A2 P05177 3/20 0.39
LMNA P02545 2/20 0.39
CYP3A4 P08684 1/20 0.39
MAOA P21397 1/20 0.39
ALDH1A1 P00352 7/20 0.38
HPGD P15428 4/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 3/20 0.38
MAPT P10636 3/20 0.38
RAB9A P51151 3/20 0.38
PDE4D Q08499 1/20 0.38
HTT P42858 1/20 0.37
RECQL P46063 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13678351 0.81 FBP1 (0.37) FBP1KDM4EAHRCYP1A2LMNA
SCHEMBL3822763 0.80 HPGD (0.33) KDM4ECYP1A2ALDH1A1HPGDGAA
SCHEMBL3823023 0.80 KDM4E (0.43) FBP1KDM4EAHRMAPK1CYP1A2
SCHEMBL3820853 0.80 CYP1A2 (0.38) FBP1KDM4EAHRMAPK1CYP1A2
SCHEMBL781841 0.79 FBP1 (0.56) FBP1KDM4EAHRMAPK1CYP1A2
SCHEMBL3274432 0.79 MAPT (0.47) FBP1KDM4EAHRCYP1A2LMNA
SCHEMBL20378385 0.78 KDM4E (0.38) FBP1KDM4EAHRMAPK1CYP1A2
Hydrochloric Acid SCHEMBL3822769 0.77 POLB (0.33) HTT
SCHEMBL3822179 0.77 FBP1 (0.41) FBP1KDM4EAHRMAPK1CYP1A2
SCHEMBL14019446 0.76 TARBP2 (0.46) FBP1KDM4ECYP1A2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 FBP1 45/4885KDM4E 1955/4885AHR 3629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.